PMID: 8602490Sep 1, 1995Paper

Who is a successful quitter? One-year follow-up of a National Tobacco Quit and Win Contest in Sweden

Scandinavian Journal of Social Medicine
P TillgrenL E Holm

Abstract

The first nation-wide Quit and Win Contest in Sweden was held in 1988 with 12,840 participants. This corresponds to a participant rate of 6.4 per 1,000 daily tobacco users in Sweden. In order to follow up the long-term effects of cessation and to analyse the determinants for successful cessation, a panel (n = 946) of randomized participants were followed-up at 6 and 12 months with a mailed questionnaire. This gave a complete set of data for 557 (panel) respondents. Available baseline data from the participants' entry forms included sex, age, occupation, specific tobacco habits, quitting attempts during the previous year, and place of residence. At the 12-month follow-up 21% had been tobacco-free for the whole year. In addition 9% of the participants relapsed into tobacco-use, then quit again and were tobacco-free at the 12-month follow-up. The success rate for those participants (14%) who used smokeless tobacco (oral snuff) was similar to that of smokers. The logistic regression showed a significantly better prognosis for success among those without any earlier quitting attempts during the previous year (OR 2.35), if the subjects participated of their own volition rather than having been recruited by a non-tobacco user (OR 1.74...Continue Reading

References

Aug 1, 1992·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·P TillgrenL E Holm
Feb 1, 1992·American Journal of Epidemiology·R B CoambsL T Kozlowski
May 1, 1992·American Journal of Epidemiology·K M FreundJ Stokes
Jan 1, 1992·Preventive Medicine·H J KorhonenP Puska
Mar 1, 1991·Preventive Medicine·R E DuNahD K Ahn
Sep 1, 1990·British Journal of Addiction·P Nordgren, L Ramström
Jan 1, 1990·Health Education Quarterly·T J GlynnJ C Gruman
Jan 1, 1990·Journal of Clinical Epidemiology·W P McWhorterM E Mattson
Jul 1, 1990·Preventive Medicine·R P SloanM A Kristiansen
Feb 1, 1987·American Journal of Public Health·D G AltmanJ W Farquhar
Mar 1, 1987·Preventive Medicine·J P ElderR A Carleton
Jan 1, 1986·Health Education Quarterly·V J StrecherI M Rosenstock
Jul 1, 1973·American Journal of Epidemiology·T W OakesC C Seltzer
Aug 1, 1984·Journal of the American Academy of Dermatology·H L Arnold
Jul 1, 1994·American Journal of Public Health·D L PatrickS Kinne
Jun 1, 1993·Quality Assurance in Health Care : the Official Journal of the International Society for Quality Assurance in Health Care·M A Hartley, A Rassaby
Jan 1, 1990·International Quarterly of Community Health Education·L Wallack, R Sciandra

❮ Previous
Next ❯

Citations

Aug 31, 1999·Addictive Behaviors·D K HatsukamiR Bliss
Nov 30, 1999·Journal of the American College of Cardiology·F HuhtasaariK Asplund
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·D K Hatsukami, H H Severson
Jun 2, 2001·Tobacco Control·E MonsóJ Morera
Jun 14, 2014·BMC Public Health·Marewa GloverWarren Moetara
May 20, 2003·Addiction·Jon O EbbertLowell C Dale
Mar 21, 2002·Journal of Internal Medicine·K Asplund
May 31, 2003·Stroke; a Journal of Cerebral Circulation·Kjell AsplundBirgitta Stegmayr
May 1, 1996·Health Care for Women International·K DavidsonM Fioretos
Apr 1, 1997·Behavioral Medicine·K L SkaarE R Gritz
Dec 13, 2005·Journal of Public Health Management and Practice : JPHMP·Richard O'ConnorK Michael Cummings
Dec 13, 2005·Journal of Public Health Management and Practice : JPHMP·Larry W HawkK Michael Cummings
Feb 21, 2019·The Cochrane Database of Systematic Reviews·Thomas R FanshaweNicola Lindson
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Kate Cahill, Rafael Perera
Feb 15, 2001·American Journal of Preventive Medicine·D P HopkinsUNKNOWN Task Force on Community Preventive Services
Apr 22, 2003·Progress in Cardiovascular Diseases·Kjell Asplund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.